Department of Cardiology, the Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China.
Aging Dis. 2023 Dec 1;14(6):2003-2014. doi: 10.14336/AD.2023.0506.
Determination of erythrocyte lifespan is an important part of the diagnosis of hemolytic diseases. Recent studies have revealed alterations in erythrocyte lifespan among patients with various cardiovascular diseases, including atherosclerotic coronary heart disease, hypertension, and heart failure. This review summarizes the progress of research on erythrocyte lifespan in cardiovascular diseases.
红细胞寿命的测定是溶血性疾病诊断的重要组成部分。最近的研究揭示了各种心血管疾病患者的红细胞寿命发生了改变,包括动脉粥样硬化性冠心病、高血压和心力衰竭。本文综述了红细胞寿命在心血管疾病中的研究进展。